Highlights and Quick Summary
- Capital Expenditures for the quarter ending June 30, 2023 was $-250 Thousand (a 8.7% increase compared to previous quarter)
- Year-over-year quarterly Capital Expenditures decreased by -71.78%
- Annual Capital Expenditures for 2022 was $-3.07 Million (a -15.23% decrease from previous year)
- Annual Capital Expenditures for 2021 was $-3.62 Million (a 211.63% increase from previous year)
- Annual Capital Expenditures for 2020 was $-1.16 Million (a -29.51% decrease from previous year)
- Twelve month Capital Expenditures ending June 30, 2023 was $-1.89 Million (a -0.58% decrease compared to previous quarter)
- Twelve month trailing Capital Expenditures decreased by -58.46% year-over-year
Trailing Capital Expenditures for the last four month:
| 30 Jun '23 | 31 Mar '23 | 31 Dec '22 | 30 Sep '22 |
|---|---|---|---|
| $-1.89 Million | $-1.9 Million | $-3.07 Million | $-4.54 Million |
Visit stockrow.com/DYN
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Capital Expenditures of Dyne Therapeutics, Inc.
Most recent Capital Expendituresof DYN including historical data for past 10 years.Interactive Chart of Capital Expenditures of Dyne Therapeutics, Inc.
Dyne Therapeutics, Inc. Capital Expenditures for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2023 | $-0.25 | $-0.23 | – | – | – |
| 2022 | $-0.52 | $-0.89 | $-0.26 | $-1.4 | $-3.07 |
| 2021 | $-1.99 | $-0.88 | $-0.74 | $-0.01 | $-3.62 |
| 2020 | $-0.72 | $-0.16 | $-0.07 | $-0.21 | $-1.16 |
| 2019 | – | – | $-0.74 | $-0.91 | $-1.65 |
| 2018 | – | – | – | – | $-0.13 |
Business Profile of Dyne Therapeutics, Inc.
Sector: Healthcare
Industry: Biotechnology